Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)

Funding Opportunity PAR-19-280 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for research projects designed to solve specific problems and paradoxes in multiple myeloma (MM) and disparities research identified as the National Cancer Institute's (NCI) Multiple Myeloma Disparities Provocative Questions (MMD PQs). These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in multiple myeloma research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of multiple myeloma and disparities research that are deemed important but have not received sufficient attention.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding